Asensus Surgical (ASXC) Stock Sees Sell-Off At Higher Level: A Good Buy Now?

The robotic surgery industry has grown at a fairly impressive clip over the...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more


New IPO Stock Therapix BioSciences (NASDAQ:TRPX) Is ...
Ocular Therapeutix OCUL Stock Price is down 21%, can...
Perceptive Advisors is Buying Zogenix Inc. (NASDAQ:Z...

The robotic surgery industry has grown at a fairly impressive clip over the course of the past few years and nowadays investors are becoming increasingly interested in this particular sector. One of the companies that could be of interest to such investors is Asensus Surgical (NYSEAMERICAN:ASXC), which is currently one of the notable players in the sector thanks to its main product Senhance System.

The product is meant for providing assistance during surgeries. However, if anyone is looking to analyze the Asensus stock then it is necessary to recognize that the situation may be a bit more complex. The most important thing to note that in addition to providing assistance for surgical procedures, Senhance System is also meant for cutting costs.

On the other hand, it is also necessary to remember that the Asensus stock had been caught up in the meme stock frenzy earlier this year and rallied hard as retail investors from Reddit piled on to the stock in a big way. As a matter of fact, the stock rallied by as much as 900% at the beginning of the year in a matter of few months.

However, such gains don’t last in general and it didn’t for the Asensus stock. The company’s product is ideal for laparoscopic surgeries since it is one type of surgery that has proven to be ideal for robotic solutions. Robotic surgery is expensive but Asensus has designed Senhance System in such a way that it can reduce costs by utilizing reusable standard instruments.

Stay in the lopp :

88 Energy (EEENF) Stock Soars 35% in a Month:...

After having gone through a fair degree of volatility, the oil and gas company 88 Energy (OTCMKTS:EEENF) saw its stock make a strong

Medivolve Signs Agreement to Acquire 100% of ...
Read original article here. As part of its telehealth strategy, Medivolve has acquired a pharmacy to better serve Collection Sites telehealth patients as
Village Farms International Inc (OTCMKTS: VFF...

Village Farms International Inc (OTCMKTS: VFFIF) In A Bought Deal Offering Worth $13.5 Million


VFFIFVillage Farms International Inc

related post

Skip to content